Duchenne Muscular Dystrophy Treatment MarketSize and Trends

The global Duchenne muscular dystrophy treatment market was valued at US$ 2,787.6 Mn in 2022 and is forecast to reach a value of US$ 63,519.4 Mn by 2030 at a CAGR of 47.85% between 2023 and 2030. The Duchenne muscular dystrophy treatment market is experiencing strong growth due to the increase in prevalence of Duchenne muscular dystrophy and increase in demand for novel drugs or therapies. Moreover, increase in research and development (R&D) and increase in awareness among people about DMD and available drugs/therapies is expected to boost the growth of the market. However, factors such as lack of standardization and stringent rules and regulations are expected to hamper growth of the market.

Figure 1. Global Duchenne Muscular Dystrophy Treatment Market Share (%), by Region, 2023

Global Duchenne Muscular Dystrophy Treatment Market Trends:

Increase in number of clinical trials is a recent trend

There has been a significant increase in the discovery and development of pharmaceutical drugs. Clinical trials are being conducted worldwide to evaluate potential treatments for DMD. Pharma companies and drug manufacturers worldwide have completed number of clinical trials for DMD over the past few years. Moreover, multiple potential candidate are currently in Phase II and III across the world. This trend is expected to continue over the forecast period.

Introduction of novel drugs/therapies is another trend

Players in the market are focusing on developing and launching safe and effective drugs/therapies for the treatment of Duchenne muscular dystrophy. Moreover, players in the market are focusing on launching exon skipping technology or technologies (exon skipping is a treatment approach for people with DMD), which is a significant factor augmenting the growth of the market. This trend is expected to continue over the forecast period.

Figure 2. Global Duchenne Muscular Dystrophy Treatment Market Share (%), by Therapeutic approach, 2023